Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Pharmaceutical Analysis
  4. Fast Track Articles
  5. Fast Track Article
image of Development And Validation of In-Vitro Release Test (IVRT) Method for Topical Complex Generic - Ganciclovir Ophthalmic Gel

Abstract

Background

The release test (IVRT) is a tool to measure the amount and the release rate of active pharmaceutical compounds released from topical semisolid dosage forms. The IVRT provides significant information for product performance assessment and evaluation. It is also used to assess the bioequivalence study (biowaivers) for topical semisolid products.

Objective

The study aims to develop and validate the IVRT method for qualitative and quantitative estimation of ganciclovir topical products and to demonstrate the similarity between the marketed reference product and the in-house test product of ganciclovir ophthalmic gel.

Method

The method was developed using a vertical diffusion cell with a synthetic cellulose membrane, simulated tear fluid as the receiver media, and UV detection. The IVRT study was performed at 100rpm and 32oC for 6hr. The marketed formulation containing 0.15%w/w ganciclovir was used as a reference.

Result

The in-house test product of ganciclovir met all characterization criteria. The analytical method was optimized and validated with a concentration range of 2-14μg/ml and a regression coefficient of 0.9997 as per the ICH guideline. The developed IVRT method was simple, economical, linear, robust, reproducible, sensitive, specific, and selective to evaluate the drug release from the formulation. The %recovery at 6hr was found to be 84.43% and 78.68% for reference and test product of ganciclovir ophthalmic gel with correlation coefficient R2 0.9947 and 0.9921, respectively, this value justified the biowaivers between the reference and test formulation.

Conclusion

This method can be utilized to check topical semisolid product quality, product performance, and product uniformity. Additionally, it can also be used to waive the requirement for bioequivalency studies for ganciclovir ophthalmic gel.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpa/10.2174/0115734129322233241021110123
2024-10-23
2024-11-26

  • From This Site

    /content/journals/cpa/10.2174/0115734129322233241021110123
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Ueda C.T. Shah V.P. Derdzinski K. Ewing G. Flynn G. Maibach H. Marques M. Rytting H. Shaw S. Thakker K. Yacobi A. Topical and transdermal drug products. Pharmacopeial Forum 2009 35 3 750 764
    [Google Scholar]
  2. Walters K.A. Brain K.R. Topical and transdermal delivery. Pharmaceutical Preformulation and Formulation CRC press 2016 487 538
    [Google Scholar]
  3. Osborne D.W. Amann A.H. Topical Drug Delivery Formulations. Drugs and the Pharmaceutical Sciences. CRC Press Boca Raton 1989 175 178 10.1201/9780367803933
    [Google Scholar]
  4. Kanfer I. Rath S. Purazi P. Mudyahoto N.A. In vitro release testing of semi-solid dosage forms. Dissolut. Technol. 2017 24 3 52 60 10.14227/DT240317P52
    [Google Scholar]
  5. Shah V.P. In vitro release from semisolid dosage forms - What is its value?. Percutaneous Absorption Bronaugh R.L. Maibach H.I. Boca Raton Taylor & Francis Group 2005 4th ed 473 480 10.1201/9780849359033.ch34
    [Google Scholar]
  6. SUPAC-SS: Nonsterile semisolid dosage forms; scale-up and post-approval changes: Chemistry, manufacturing and controls; in vitro release testing and in vivo bioequivalence documentation. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/supac-ss-nonsterile-semisolid-dosage-forms-scale-and-post-approval-changes-chemistry-manufacturing 1997
  7. Thakker K. Summary report on workshop on in vitro release test (IVRT) and In vitro permeation test (IVPT) methods. Dissolut. Technol. 2021 28 4 50 52 10.14227/DT280421P450
    [Google Scholar]
  8. Dandamudi S. In vitro bioequivalence data for a topical product: Bioequivalence review perspective. 2017 Available from: https://kinampark.com/PL/files/FDA%20Dandamudi%202017%2C%20In%20vitro%20BE%20data%20for%20a%20topical%20products.pdf
  9. Siewert M. Dressman J. Brown C.K. Shah V.P. Aiache J.M. Aoyagi N. Bashaw D. Brown C. Brown W. Burgess D. Crison J. DeLuca P. Djerki R. Dressman J. Foster T. Gjellan K. Gray V. Hussain A. Ingallinera T. Klancke J. Kraemer J. Kristensen H. Kumi K. Leuner C. Limberg J. Loos P. Margulis L. Marroum P. Moeller H. Mueller B. Mueller-Zsigmondy M. Okafo N. Ouderkirk L. Parsi S. Qureshi S. Robinson J. Shah V. Siewert M. Uppoor R. Williams R. FIP/AAPS guidelines to dissolution/In vitro release testing of novel/special dosage forms. AAPS PharmSciTech 2003 4 1 E7 10.1208/pt040107 12916916
    [Google Scholar]
  10. Draft guideline on quality and equivalence of topical products. 2018 Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-quality-and-equivalence-topical-products_en.pdf
  11. Olejnik A. Goscianska J. Nowak I. Active compounds release from semisolid dosage forms. J. Pharm. Sci. 2012 101 11 4032 4045 10.1002/jps.23289 22886492
    [Google Scholar]
  12. Klein R.R. Heckart J.L. Thakker K.D. In vitro release testing methodology and variability with the vertical diffusion cell (VDC). Dissolut. Technol. 2018 25 3 52 61 10.14227/DT250318P52
    [Google Scholar]
  13. Semisolid drug products - Performance tests. Available from: https://doi.usp.org/USPNF/USPNF_M5695_01_01.html
  14. In vitro release test studies for topical drug products submitted in ANDAs. 2022 Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/in-vitro-release-test-studies-topical-drug-products-submitted-andas
  15. Tiffner K.I. Kanfer I. Augustin T. Raml R. Raney S.G. Sinner F. A comprehensive approach to qualify and validate the essential parameters of an In vitro release test (IVRT) method for acyclovir cream, 5. Int. J. Pharm. 2018 535 1-2 217 227 10.1016/j.ijpharm.2017.09.049 28935255
    [Google Scholar]
  16. Modi P.B. Shah N.J. Optimization of an in vitro release test for topical formulations containing eberconazole nitrate and mometasone furoate. Pharma Chem. 2015 7 8 1 9
    [Google Scholar]
  17. Rath S. Kanfer I. A validated IVRT method to assess topical creams containing metronidazole using a novel approach. Pharmaceutics 2020 12 2 119 10.3390/pharmaceutics12020119 32028557
    [Google Scholar]
  18. Ramanah A. Khamanga S.M. Walker R.B. Development and validation of an in vitro release test for ketoconazole (KZ) on semi-solid dosage forms. 2014 Available from: https://d1wqtxts1xzle7.cloudfront.net/69599932/Development_and_Validation_of_an_in_vitr20210913-23382-lldsxm-libre.pdf?1631595032=&response-content-disposition=inline%3B+filename%3DDevelopment_and_Validation_of_an_in_vitr.pdf&Expires=1728981430&Signature=MlzdO-mx5-OCZfymNr4cjL8KQqrv3ZVl1BRo~0DtXyerYbfdXP0BJ~coC30Z-NoWEQC1bVhL34Gx6RZBpYXeo2PA05YvAYmuJ8QIm~vB3Jyax8sDBeFOk1X6~R~k49BhS20ZhuCz4-bnaEijj54qWZMIJs9tLTuGSiaA3Ys-3sao0QjKZOfY-C3cqJrYXwwx32zEOuJREbjfWkLslZCW4a37bruzB1LURsaXM5zpX2i1WruXxvI33jAUiJgVX-7It-bpdt01CBLWHG02Tiu4iFHocb~lWc4FUiG-Zh5xjK4LkViTGpjdn-pn5ANkpn~YylnNBFCDGVxDRlBKj8tw8Q__&Key-Pair-Id=APKAJLOHF5GGSLRBV4ZA
  19. Bezuglaya E. Liapunova A. Zinchenko I. Lyapunov N. Study of factors affecting the in vitro release of dexpanthenol from solutions and topical semi-solid preparations. ScienceRise. Pharm. Sci. 2023 3 (43) 4 15
    [Google Scholar]
  20. Bao Q. Shen J. Jog R. Zhang C. Newman B. Wang Y. Choi S. Burgess D.J. In vitro release testing method development for ophthalmic ointments. Int. J. Pharm. 2017 526 1-2 145 156 10.1016/j.ijpharm.2017.04.075 28461266
    [Google Scholar]
  21. Shettar A. Shankar V. Murthy N. Shivkumar H.N. Modified in vitro release testing method for ophthalmic suspensions using franz diffusion cell. AAPS PharmSci 2019
    [Google Scholar]
  22. Mudyahoto N.A. Rath S. Ramanah A. Kanfer I. In vitro release resting (IVRT) of topical hydrocortisone acetate creams: A novel approach using positive and negative controls. Dissolut. Technol. 2020 27 1 6 12 10.14227/DT270120P6
    [Google Scholar]
  23. Klein R.R. Tao J.Q. Wilder S. Burchett K. Bui Q. Thakker K.D. Development of an in vitro release test (IVRT) for a vaginal microbicide gel. Dissolut. Technol. 2010 17 4 6 10 10.14227/DT170410P6
    [Google Scholar]
  24. Hicran G.D. Ecem K.Ş. Ceren O.G. Banu Ö.A. Mine U.G. Method development and validation of in vitro release test for fluorometholone ophthalmic suspension using franz diffusion cell system. Glob J Pharmaceu Sci. 2021 9 2 555758
    [Google Scholar]
  25. Manian M. Jain P. Vora D. Banga A.K. Formulation and evaluation of the in vitro performance of topical dermatological products containing diclofenac sodium. Pharmaceutics 2022 14 9 1892 10.3390/pharmaceutics14091892 36145640
    [Google Scholar]
  26. Cetin D. Turker T.G. Yilmaz N. Karakoy B.A. Comparative in vitro release test using franz diffusion cell for luliconazole % 1 cream with reference drug product. Available from: https://www.labmate-online.com/article/chromatography/1/bilim-pharmaceuticals/comparative-in-vitro-release-test-using-franz-diffusion-cell-for-luliconazole-1-cream-with-reference-drug-product/3019 2022
  27. Bezuglaya E. Ivashchenko H. Lyapunov N. Zinchenko I. Liapunova A. Stolper Y. Liapunov O. Pukhova T. Study of factors affecting the in vitro release of diclofenac sodium from hypromelose-based gels. ScienceRise. Pharm. Sci. 2021 5 33 12 31
    [Google Scholar]
  28. Pippalla S. Nekkalapudi A.R. Jillellamudi S.B. Reddy M.P. Kumar C.V. A stability-indicating, reversed-phase HPLC method for quantification of assay and organic impurities in doxycycline hyclate bulk and parenteral dosage forms. Biomed. Chromatogr. 2023 37 6 e5626 10.1002/bmc.5626 36930874
    [Google Scholar]
  29. Zafar A. Alsaidan O.A. Imam S.S. Yasir M. Alharbi K.S. Khalid M. Formulation and evaluation of moxifloxacin loaded bilosomes in-situ gel: Optimization to antibacterial evaluation. Gels 2022 8 7 418 10.3390/gels8070418 35877503
    [Google Scholar]
  30. Khan N. Aqil M. Imam S.S. Ali A. Development and evaluation of a novel in situ gel of sparfloxacin for sustained ocular drug delivery: In vitro and ex vivo characterization. Pharm. Dev. Technol. 2015 20 6 662 669 10.3109/10837450.2014.910807 24754411
    [Google Scholar]
  31. Imam S.S. Gilani S.J. Zafar A. Jumah M.N.B. Alshehri S. Formulation of miconazole-loaded chitosan–carbopol vesicular gel: optimization to in vitro characterization, irritation, and antifungal assessment. Pharmaceutics 2023 15 2 581 10.3390/pharmaceutics15020581 36839903
    [Google Scholar]
  32. Zafar A. Yasir M. Singh L. Jafar M. Warsi M.H. Panda D.S. Luteolin-loaded invasomes gel for transdermal delivery: Development, optimization, in-vitro, and preclinical evaluation. J. Oleo Sci. 2024 73 9 1221 1240 10.5650/jos.ess24041 39218639
    [Google Scholar]
/content/journals/cpa/10.2174/0115734129322233241021110123
Loading
Development And Validation of In-Vitro Release Test (IVRT) Method for Topical Complex Generic - Ganciclovir Ophthalmic Gel
Bentham Science Publishers ; https://doi.org/10.2174/0115734129322233241021110123
/content/journals/cpa/10.2174/0115734129322233241021110123
/content/journals/cpa/10.2174/0115734129322233241021110123
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: method development and validation ; topical formulation ; In-vitro ; ophthalmic gel ; biowaiver ; ganciclovir ; in-house formulation ; release test(IVRT)

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test